Improved survival of Hodgkin's patients in South-East Netherlands since 1972

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 436-441

  Van Spronsen, D J ^a   Dijkema, I M ^a   Vrints, L W ^a,b   Hofstra, G ^c   Crommelin, M A ^a,b   Erdkamp, F L G ^b   Coebergh, J W W ^b,c   Breed, W P M ^a,b  

^a CATHARINA HOSPITAL   (Netherlands)

^b The Netherlands   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

histology; Hodgkin's disease; population based; prognosis; registry; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; MALE; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031105978     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)89019-3     Document Type: Article

References (26)

1. Weinshel EL, Peterson BA. Hodgkin's disease. Cancer J Clin. 43:1993;327-346.
2. Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med. 326:1992;678-687.
3. Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease: a report from the International Data base on Hodgkin's Disease. Semin Oncol. 17:1990;758-768.
4. Mazza P, Bocchia M, Zinzani PL, et al. Hodgkin's disease: summary of twenty years' experience. Haematologica. 77:1992;487-493.
5. Biti G, Cellai E, Magrini SM, Papi MG, Ponticelli P, Boddi V. Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution. Int J Radiation Oncol Biol Phys. 29:1994;25-31.
6. Van Rijswijk R, Verbeek J, Haanen C, Dekker A, et al. De resultaten van de behandeling van de ziekte van Hodgkin: 15 jaar ervaring van de universiteitsklinieken van Nijmegen en Utrecht. Ned Tijdschr Geneeskd. 131:1987;1866-1870.
7. Storm HH, Clemmensen J. Survival of Danish cancer patients 1943-87. APMIS. 1993;189-193.
8. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of Cancer Patients in Europe: the EUROCARE Study, 1978-85. 1995;363-372 Lyon, Scientific Publications.
9. Davis S, Dahlberg S, Myers MH, Chen A, Steinhorn SC. Hodgkin's disease in the United States: a comparison of patients characteristics and survival in the Centralised Cancer Patient Data System and the Surveillance Epidemiology and End Results Program. J Natl Cancer Inst. 78:1987;471-478.
10. Medeiros LJ, Greiner TC. Hodgkin's disease. Cancer. 75:1995;357-369.
11. Erdkamp FLG, Wijlhuizen ThJ, van Dam FE. De ziekte van Hodgkin: een regionaal, retrospectief onderzoek. Ned Tijdschr Geneeskd. 132:1988;1801-1806.
12. Friedenberg WR, Dirks P, Beltaos E, et al. Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-79). Cancer. 57:1986;12-17.
13. Hoppe RT, Hanlon AL, Hanks GE, Owen JB. Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983: the patterns of care study. Cancer. 74:1994;3198-3203.
14. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 26:1966;1063-1081.
15. Bennet MH, Maclennan KA, Easterling MJ, Hudson BV, Jeliffe AM, Hudson GV. The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no 22). Clin Radiol. 34:1983;497-501.
16. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 31:1971;1860-1861.
17. Hakulinen T. Cancer survival corrected for heterogeneity in patients withdrawal. Biometrics. 38:1982;933-942.
18. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Appl Stat. 36:1987;309-317.
19. Berkson J, Gage RP. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 25:1950;270-286.
20. Gobbi PG, Comelli M, Grignani GE, Piersca C, Bertoloni D, Ascari E. Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from IDHD. Haemotologica. 79:1994;241-255.
21. Van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20 year follow-up study. J Clin Oncol. 12:1994;312-325.
22. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 169:1992;1241-1247.
23. Hartge P, Devesa SS, Fraumeni JF Jr. Doll R, Fraumeni JF Jr, Muir CS. Trends in Cancer Incidence and Mortality. 20:1994;423-453 Cold Spring Harbor Laboratory Press, New York.
24. Boyle P, Soukop M, Scully C, et al. Improving prognosis of Hodgkin's disease in Scotland. Eur J Cancer Clin Oncol. 24:1988;229-234.
25. Hooper WC, Holman RC, Stine TW, Chorba TL. Hodgkin's disease mortality in the United States. Cancer. 70:1992;1166-1171.
26. Van Spronsen DJ, van der Heijden LH. Hodgkin's disease. Coebergh JWW, van der Heijden L, Janssen-Heijnen MLG. Cancer Incidence and Survival in the South-East Netherlands 1955-94. 1995;82-83 Comprehensive Cancer Center South, Eindhoven.